vs
Side-by-side financial comparison of BEYOND MEAT, INC. (BYND) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
BEYOND MEAT, INC. is the larger business by last-quarter revenue ($61.6M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). On growth, BEYOND MEAT, INC. posted the faster year-over-year revenue change (-19.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-49.8M). Over the past eight quarters, BEYOND MEAT, INC.'s revenue compounded faster (-9.7% CAGR vs -20.2%).
Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BYND vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $47.7M |
| Net Profit | — | $-2.3M |
| Gross Margin | -11.5% | — |
| Operating Margin | -211.4% | 14.3% |
| Net Margin | — | -4.8% |
| Revenue YoY | -19.7% | -47.3% |
| Net Profit YoY | — | -200.9% |
| EPS (diluted) | $0.68 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | $47.7M | ||
| Q3 25 | $70.2M | $122.1M | ||
| Q2 25 | $75.0M | $85.2M | ||
| Q1 25 | $68.7M | $41.1M | ||
| Q4 24 | $76.7M | $90.5M | ||
| Q3 24 | $81.0M | $91.6M | ||
| Q2 24 | $93.2M | $94.4M | ||
| Q1 24 | $75.6M | $74.9M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $-110.7M | $40.1M | ||
| Q2 25 | $-29.2M | $23.6M | ||
| Q1 25 | $-52.9M | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $-26.6M | $3.6M | ||
| Q2 24 | $-34.5M | $-860.0K | ||
| Q1 24 | $-54.4M | $-4.2M |
| Q4 25 | -11.5% | — | ||
| Q3 25 | 10.3% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | -1.5% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 14.7% | — | ||
| Q1 24 | 4.9% | — |
| Q4 25 | -211.4% | 14.3% | ||
| Q3 25 | -160.0% | 61.8% | ||
| Q2 25 | -46.6% | 53.2% | ||
| Q1 25 | -81.8% | -70.7% | ||
| Q4 24 | -49.3% | 34.8% | ||
| Q3 24 | -38.2% | 28.0% | ||
| Q2 24 | -36.4% | 26.5% | ||
| Q1 24 | -70.7% | 14.7% |
| Q4 25 | — | -4.8% | ||
| Q3 25 | -157.6% | 32.8% | ||
| Q2 25 | -39.0% | 27.7% | ||
| Q1 25 | -77.0% | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | -32.8% | 4.0% | ||
| Q2 24 | -37.0% | -0.9% | ||
| Q1 24 | -71.9% | -5.6% |
| Q4 25 | $0.68 | $0.01 | ||
| Q3 25 | $-1.44 | $0.23 | ||
| Q2 25 | $-0.38 | $0.14 | ||
| Q1 25 | $-0.69 | $-0.23 | ||
| Q4 24 | $-0.65 | $0.03 | ||
| Q3 24 | $-0.41 | $0.02 | ||
| Q2 24 | $-0.53 | $-0.01 | ||
| Q1 24 | $-0.84 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $203.9M | $215.5M |
| Total DebtLower is stronger | $415.7M | — |
| Stockholders' EquityBook value | $-997.0K | $-261.8M |
| Total Assets | $614.7M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $203.9M | $215.5M | ||
| Q3 25 | $117.3M | $140.4M | ||
| Q2 25 | $103.5M | $92.9M | ||
| Q1 25 | $102.1M | $108.5M | ||
| Q4 24 | $131.9M | $88.6M | ||
| Q3 24 | $121.7M | $88.2M | ||
| Q2 24 | $144.9M | $105.5M | ||
| Q1 24 | $157.9M | $121.5M |
| Q4 25 | $415.7M | — | ||
| Q3 25 | $1.2B | $199.5M | ||
| Q2 25 | $1.2B | $199.3M | ||
| Q1 25 | $1.1B | $199.2M | ||
| Q4 24 | $1.1B | $199.0M | ||
| Q3 24 | $1.1B | $198.8M | ||
| Q2 24 | $1.1B | $198.6M | ||
| Q1 24 | $1.1B | $398.3M |
| Q4 25 | $-997.0K | $-261.8M | ||
| Q3 25 | $-784.1M | $-264.2M | ||
| Q2 25 | $-677.0M | $-308.2M | ||
| Q1 25 | $-649.5M | $-334.1M | ||
| Q4 24 | $-601.2M | $-301.3M | ||
| Q3 24 | $-611.9M | $-311.3M | ||
| Q2 24 | $-590.0M | $-321.7M | ||
| Q1 24 | $-561.4M | $-330.5M |
| Q4 25 | $614.7M | $396.9M | ||
| Q3 25 | $599.7M | $396.1M | ||
| Q2 25 | $691.7M | $342.9M | ||
| Q1 25 | $643.8M | $327.2M | ||
| Q4 24 | $678.1M | $350.9M | ||
| Q3 24 | $692.9M | $389.5M | ||
| Q2 24 | $711.2M | $395.6M | ||
| Q1 24 | $735.0M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-46.8M | $74.6M |
| Free Cash FlowOCF − Capex | $-49.8M | $74.6M |
| FCF MarginFCF / Revenue | -80.8% | 156.3% |
| Capex IntensityCapex / Revenue | 4.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-157.2M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-46.8M | $74.6M | ||
| Q3 25 | $-38.8M | $47.6M | ||
| Q2 25 | $-33.2M | $-15.1M | ||
| Q1 25 | $-26.1M | $20.0M | ||
| Q4 24 | $-29.0M | $15.2M | ||
| Q3 24 | $-22.0M | $9.9M | ||
| Q2 24 | $-16.0M | $33.5M | ||
| Q1 24 | $-31.8M | $45.0M |
| Q4 25 | $-49.8M | $74.6M | ||
| Q3 25 | $-41.7M | $47.6M | ||
| Q2 25 | $-35.1M | $-15.1M | ||
| Q1 25 | $-30.6M | $19.9M | ||
| Q4 24 | $-35.4M | — | ||
| Q3 24 | $-24.1M | $9.9M | ||
| Q2 24 | $-17.3M | $33.4M | ||
| Q1 24 | $-33.0M | $44.9M |
| Q4 25 | -80.8% | 156.3% | ||
| Q3 25 | -59.4% | 39.0% | ||
| Q2 25 | -46.9% | -17.7% | ||
| Q1 25 | -44.6% | 48.4% | ||
| Q4 24 | -46.2% | — | ||
| Q3 24 | -29.7% | 10.8% | ||
| Q2 24 | -18.6% | 35.4% | ||
| Q1 24 | -43.7% | 60.0% |
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 4.1% | 0.0% | ||
| Q2 25 | 2.6% | 0.0% | ||
| Q1 25 | 6.5% | 0.1% | ||
| Q4 24 | 8.4% | 0.0% | ||
| Q3 24 | 2.5% | 0.0% | ||
| Q2 24 | 1.4% | 0.1% | ||
| Q1 24 | 1.6% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
